Dynetherapeutics
Senior Manager, US Medical Affairs
Waltham, MA. Posted 4 months ago
The role
This person will support the execution of US Medical Affairs strategy for the Duchenne Muscular Dystrophy program. They will contribute to launch readiness, KOL engagement, congress execution, and medical education efforts.
What you will do
- Supports execution of US Medical Affairs tactical plans for the DMD program
- Assists in implementing scientific platform materials, congress planning, and medical education initiatives
- Contributes to cross-functional launch readiness activities
- Supports development and deployment of DMD-focused scientific materials, disease state education resources, and field medical tools
- Partners with the US MSL team to support KOL identification, engagement planning, insight gathering, and field metric tracking
- Translates field insights into actionable recommendations
- Tracks and monitors field activity and engagement effectiveness
- Contributes to development of scientific materials, field tools, and educational content
- Provides Medical review for promotional materials through the Promotional Review Committee (PRC)
- Supports planning and execution of medical congresses and US advisory boards
Required qualifications
- Advanced scientific or clinical degree required (PhD, PharmD, MD, or equivalent)
- 7+ years of relevant Medical Affairs experience in pharmaceutical or biotechnology industry
- Experience supporting US-based medical tactics, congress activities, or field medical programs
- Strong scientific acumen with ability to translate clinical data for diverse audiences
- Excellent written and verbal communication skills
- Ability to operate effectively in a fast-paced, evolving environment with competing priorities
- Demonstrated ability to build collaborative relationships with internal and external
- Travel up to 25%, including occasional overnight and weekend travel
- Positive team orientation with strong alignment to Dyne’s Core Values
- Passion for improving the lives of patients with neuromuscular diseases
Nice to have
- Rare disease experience preferred
- neuromuscular disease experience a plus
About the company
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations.